About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Mylan Suit Is a Witchhunt for Company's Internal Moles, Paper Claims

By Jim Edwards | Oct 1, 2009

Mylan’s lawsuit against the Pittsburgh Post-Gazette is nothing but an extension of its internal witch-hunt for the identities of executives who have been leaking information to the paper, the P-G claims.

Mylan sued the P-G after it broke a devastating story that alleged safety violations at Mylan’s Morgantown, Pa., plant. The FDA later investigated and cleared the site for further business, but the FDA confirmed that software had been overridden by Mylan workers:

“No data was deleted, and the audit trails were intact for each instance where the software was overridden by the operator,” according to the agency’s statement.

The P-G argues in papers filed in response to the suit:

Mylan’s suit is aimed, not at meritless efforts of holding the Post-Gazette liable, but at attempting to uncover the Post-Gazette’s sources of information.

The back story: Mylan and the P-G have a long history of beefs, making this suit personal. The litigation will inevitably be of the entertaining “scorched-earth” variety.”

And finally: P-G claims its story was “meticulously accurate.”

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Pittsburgh Post-Gazette countersues Mylan

    Reuters - 54 days 9 hours 50 minutes ago

    This one comes in on the wrong side of the weekend, but it’s worth some attention to people who follow the media and follow financial news: The Pittsburgh Post-Gazette sued pharmaceutical company Mylan on Friday — that action itself a countersuit to Mylan’s lawsuit against the paper. (Read the documents for yourself at this blog.) Mylan...

  • Mylan sues newspaper over stories alleging plant deficiencies

    Scrip News - 93 days 17 hours 15 minutes ago

    Mylan Laboratories has filed a civil lawsuit against the Pittsburgh Post-Gazette newspaper, charging that the paper published a series of "sensational and misleading" articles on improperly obtained and misconstrued confidential internal

  • Mylan Seeks Names of Moles; Internal Probe Failed to Find Them

    BNET Pharma - 93 days 5 hours 55 minutes ago

    Mylan is looking for the internal moles who leaked documents to the Pittsburgh Post-Gazette about workers who overrode manufacturing software at

  • Mylan Sues Newspaper Over Controversial Article

    Pharmalot - 19 days 19 hours 14 minutes ago

    The drugmaker filed a defamation lawsuit against The Pittsburgh Post-Gazette, accusing the paper of mischaracterizing its actions, The Wall Street Journal reports. Mylan claims the paper “intentionally and misleadingly omitted, juxtaposed and distorted the facts” in a July article saying Mylan workers routinely violated quality-control...

  • Newspaper claims Mylan is using US suit to find which employees leaked information

    Scrip News - 46 days 17 hours 12 minutes ago

    The Pittsburgh Post-Gazette is asking a federal court in the Northern District of West Virginia to dismiss an August 19th lawsuit filed by Mylan Laboratories over a news story based on an internal company report concerning the company's

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here